The work has been performed in the laboratory of Dr. Marc Pellegrini, Laboratory Head, Infection and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia and will be presented by Dr. Greg Ebert. The date ... Morningstar.com, 5 days ago
TETRALOGIC PHARMACEUTICALS : to Present Data From Pre-Clinical Studies With Hepatitis B at the 2014 International Meeting on Molecular Biology of Hepatitis B Viruses - 4 Traders, 5 days ago
on Thursday said that its plant at Puducherry has commenced its additional line of production of suppositories - a unique feature which only a few pharmaceutical companies have. This will enable the company to export these products to semi- and non-regulated ...Business Line, 1 month ago
NIH awards $300,000 grant to Acura Pharma for phase I development of Limitx abuse deterrent technology
Acura Pharmaceuticals, a specialty pharmaceutical company, has been awarded a $300,000 grant (the Grant) by the National Institute On Drug Abuse (NIDA) of the National Institutes of Health (NIH) to fund phase I development of Acura's new, early ...PharmaBiz, 2 days ago Acura Pharmaceuticals Receives Grant From National Institutes of Health to Fund Limitx(TM) Novel Abuse Deterrent Technology Franklin Credit Management Corporation, 5 days ago Acura Pharmaceuticals, Inc. Receives Grant From National Institutes of Health (NIH) To Fund Limitx Novel Abuse Deterrent Technology BioSpace, 5 days ago Acura Pharmaceuticals, Inc. Provides Update On FDA Discussions Surrounding Development Of Aversion Hydrocodone With Acetaminophen Tablet BioSpace, 2 weeks ago
When Heather Bresch joined pharmaceutical firm Mylan 22 years ago as a secretary in the quality assurance department, the company had roughly $100 million in revenues. Now Mylan's CEO, Bresch is running a business that had $7 billion in sales last ...Fortune, 4 days ago
Delivery Of New Instrument Adds New High Voltage Leak Testing Capabilities Whitehouse Laboratories is excited to announce that it has renewed its long term partnership with PTI Inspection Systems that will enable it to continue to provide clients ...PRWeb, 4 days ago Medical Couriers in the US Industry Market Research Report from IBISWorld Has Been Updated Digital Journal, 1 week ago
Operator Good day, ladies and gentlemen, and welcome to the BioReference Laboratories Inc. Third Quarter 2014 Earnings Conference Call. My name is Tuanda, and I will be your coordinator for today. [Operator Instructions] As a reminder, this ...Seeking Alpha, 5 days ago
How will the megatrends play out in Mexico? Healthcare challenges and opportunities in the Mexican market
Editor's Note: According to a new GlobalData report, Mexico's pharmaceutical industry will be worth approximately $22.5 billion by 2020. Combined with the medical device industry—expected to grow to $5.4 billion over the same period—the total ...Lexology, 5 days ago
PR Newswire HORSHOLM, Denmark, Aug. 20, 2014 HORSHOLM, Denmark , Aug. 20, 2014 /PRNewswire/ -- Highlights: On 28 July the European Commission granted marketing authorization for Envarsus® for the prevention of organ rejection in ...Reuters, 1 week ago Veloxis Pharmaceuticals A/S Announces Financial Results For The First Six Months Of 2014 BioSpace, 1 week ago
Skinvisible Pharmaceuticals, Inc. announced the forming of Kintari, a new wholly-owned subsidiary to market a premium line of scientifically...
SpecialChem - Aug 18, 2014 LAS VEGAS, NV-- Skinvisible Pharmaceuticals, Inc. announced the forming of Kintari, a new wholly-owned subsidiary to market a premium line of scientifically formulated skincare products powered by the ...SpecialChem, 2 weeks ago
DENVER, Aug. 28, 2014 /PRNewswire/ -- Pharmatech initiated enrollment for its AccessPPM program after a two-year investment into this game-changing method for matching cancer patients to cancer clinical trials. Today, clinical trials target ...TickerTech.com, 4 days ago
on your WebpageAdd Widget >Get your members hooked!